Skip to main content
. 2016 Oct 11;45(4):988–997. doi: 10.1002/jmri.25486

Table 4.

Characteristics of Patients with and without ADRa

Patients without ADR (n = 35442) Patients with at least one ADR (n = 32) P‐Value (Test)
Gender 0.288 (χ2)
Missing 41 0
Male 16594 (46.9%) 12 (37.5%)
Female 18807 (53.1%) 20 (62.5%)
Age (years) 0.108 (Wilcoxon)
Missing 142 0
Mean ± SD 49.5 ± 17.9 45.6 ± 17.7
Median 50.0 43.0
Range 0.0 ‐ 98.0 2.0 ‐90.0
BMI (kg/m2) 0.422 (Fisher exact)
Missing 922 0
 < 30 30199 (87.5%) 30 (93.8%)
 ≥ 30 4321 (12.5%) 2 (6.3%)
Premedication 1.000 (Fisher exact)
Missing 571 0
No 34225 (98.1%) 32 (100.0%)
Yes 646 (1.9%) 0 (0.0%)
At least one pre‐existing risk factor 0.017 (Fisher exact)
No 21943 (61.9%) 13 (40.6%)
Yes 13499 (38.1%) 19 (59.4%)
Total volume (mL) 0.802 (Wilcoxon)
Missing 25 0
Mean ± SD 14.01 ± 4.98 14.38 ± 7.87
Median 15.00 15.00
Range 0.5 ‐53.0 3.0 ‐ 53.0
Dose (mL/kg) 0.895 (Wilcoxon)
Missing 167 0
Mean ± SD 0.21 ± 0.07 0.22 ± 0.11
Median 0.20 0.20
Range 0.0 ‐ 2.1 0.1 ‐ 0.8
Dose in class (mL/kg)  < 0.001 (χ2)
Missing 167 0
 < 0.18 9333 (26.5%) 6 (18.8%)
0.18 ‐ 0.66 25893 (73.4%) 25 (78.1%)
 > 0.66 49 (0.1%) 1 (3.1%)
a

Data were extracted from the safety population (n = 35,474 patients).